References
L.P. Zambetti, A. Mortellaro, NLRPs, microbiota, and gut homeostasis: unravelling the connection. J. Pathol. 233(4), 321–330 (2014)
M. Haneklaus, L.A. O’Neill, NLRP3 at the interface of metabolism and inflammation. Immunol. Rev. 265(1), 53–62 (2015)
K. Esposito, A. Pontillo, M. Ciotola, C. Di Palo, E. Grella, G. Nicoletti, D. Giugliano, Weight loss reduces interleukin-18 levels in obese women. J. Clin. Endocrinol. Metab. 87(8), 3864–3866 (2002)
A. Satpathy, S. Ravindra, S. Thakur, S. Kulkarni, A. Porwal, S. Panda, Serum interleukin-1β in subjects with abdominal obesity and periodontitis. Obes. Res. Clin. Pract 9(5), 513–521 (2015)
K.M. Flegal, B.K. Kit, H. Orpana, B.I. Graubard, Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309(1), 71–82 (2013)
S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr, J.A. Spertus, F. Costa; American Heart A, National Heart L, Blood I, Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation 112(17), 2735–2752 (2005)
Y. Zhong, A. Kinio, M. Saleh, Functions of NOD-like receptors in human diseases. Front. Immunol. 4, 333 (2013)
A.J. Murphy, M.J. Kraakman, H.L. Kammoun, D. Dragoljevic, M.K. Lee, K.E. Lawlor, J.M. Wentworth, A. Vasanthakumar, M. Gerlic, L.W. Whitehead, L. DiRago, L. Cengia, R.M. Lane, D. Metcalf, J.E. Vince, L.C. Harrison, A. Kallies, B.T. Kile, B.A. Croker, M.A. Febbraio, S.L. Masters, IL-18 production from the NLRP1 inflammasome prevents obesity and metabolic syndrome. Cell. Metab. 23(1), 155–164 (2016)
M.G. Netea, L.A. Joosten, The NLRP1-IL18 connection: a stab in the back of obesity-induced inflammation. Cell. Metab. 23(1), 6–7 (2016)
Y. Hitomi, M. Ebisawa, M. Tomikawa, T. Imai, T. Komata, T. Hirota, M. Harada, M. Sakashita, Y. Suzuki, N. Shimojo, Y. Kohno, K. Fujita, A. Miyatake, S. Doi, T. Enomoto, M. Taniguchi, N. Higashi, Y. Nakamura, M. Tamari, Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma. J. Allergy. Clin. Immunol. 124(4), 779–785 (2009). e6
R. Stienstra, J.A. van Diepen, C.J. Tack, M.H. Zaki, F.L. van de Veerdonk, D. Perera, G.A. Neale, G.J. Hooiveld, A. Hijmans, I. Vroegrijk, S. van den Berg, J. Romijn, P.C. Rensen, L.A. Joosten, M.G. Netea, T.D. Kanneganti, Inflammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl Acad. Sci. USA 108(37), 15324–15329 (2011)
E. Elinav, J. Henao-Mejia, R.A. Flavell, Integrative inflammasome activity in the regulation of intestinal mucosal immune responses. Mucosal Immunol. 6(1), 4–13 (2013)
M. Levy, E. Blacher, Elinav E microbiome, metabolites and host immunity. Curr. Opin. Microbiol. 35, 8–15 (2016)
J. Hung, B.M. McQuillan, C.M. Chapman, P.L. Thompson, J.P. Beilby, Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler. Thromb. Vasc. Biol. 25(6), 1268–1273 (2005)
M. Vijay-Kumar, A.T. Gewirtz, Is predisposition to NAFLD and obesity communicable? Cell. Metab. 15(4), 419–420 (2012)
C. Bing, Is interleukin-1β a culprit in macrophage-adipocyte crosstalk in obesity? Adipocyte 4(2), 149–152 (2015)
J.1 Henao-Mejia, E. Elinav, C. Jin, L. Hao, W.Z. Mehal, T. Strowig, C.A. Thaiss, A.L. Kau, S.C. Eisenbarth, M.J. Jurczak, J.P. Camporez, G.I. Shulman, J.I. Gordon, H.M. Hoffman, R.A. Flavell, Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482(7384), 179–185 (2012)
Funding
This study was supported by Sao Paulo Research Foundation (FAPESP) (Grants numbers: 2015/23395-6;) and “Conselho Nacional de Desenvolvimento Cientıfico e Tecnologico” (CNPq). A.P. is a recipient of a CNPq fellowship. J.M.R. was a recipient of a PIBIC Fellowship. V.N.C.L. is a recipient of a FAPESP-funded fellowship. D.L. is a recipient of a UFAM-funded PhD Fellowship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
Research involved human participants. All procedures performed were in accordance with the ethical standards of the Institutional Review Board of the “Santa Casa de Belo Horizonte” hospital, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
de Moraes Rodrigues, J., Souza de Lima, D., Leal, V.N. et al. Gain-of-function SNPs in NLRP3 and IL1B genes confer protection against obesity and T2D: undiscovered role of inflammasome genetics in metabolic homeostasis?. Endocrine 60, 368–371 (2018). https://doi.org/10.1007/s12020-017-1343-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-017-1343-0